Global Information
회사소개 | 문의 | 비교리스트

Scrip : Drug Discovery, 개발, 제품수명주기에 관한 분석 서비스

Scrip (Pharma Intelligence)

리서치사 SCRIP
발행정보 연간구독 상품 코드 404564
페이지 정보 영문
US $ 6,000 ₩ 7,185,000 Web Access (Single User License)

Scrip : Drug Discovery, 개발, 제품수명주기에 관한 분석 서비스 Scrip (Pharma Intelligence)
발행정보 : 페이지 정보 : 영문

변화가 극심한 의약품 시장에서 성공하기 위해서는 최신 세계 동향 및 토픽의 파악이 필수적입니다.

본 연간정보서비스는 뉴스 헤드라인 이상의 분석까지 제공하며, 순환하는 Drug Discovery, 개발 및 제품수명주기에 관한 인사이트와 분석 제공에 중점을 두고 있습니다. 반응형 웹사이트에서 제공되며, 목적에 맞춘 이메일 통지 기능 및 검색 결과의 다양한 추출 기능, 컨텐츠 수집, 송신, 공유에 의해 고객이 실제로 필요로 하는 내용에 따른 서비스 맞춤화도 가능합니다. 본 서비스가 제공하는 인사이트, 분석과 견해의 신뢰성은 전 세계의 주요 지역을 기반으로 하는 리더 및 유력 저널리스트 등 업계 전문가들에 의해 얻은 것입니다.

Scrip의 특징

  • 20명 이상의 애널리스트가 공개하는 실시간 분석에 모바일, 태블릿, PC로 액세스 가능
  • 미국, 유럽 및 아시아태평양 지역의 상황으로부터 본 독자적 전망
  • 최첨단 기업의 상세 조사 결과에 의한 새로운 경향 및 테크놀러지 평가
  • 기업 동향 : M&A, 거래 정보, 결산 정보, 파트너십 등
  • 제품 개발 상황 : 임상시험의 결과, 승인, 출시, 시판 후 업데이트 정보 등에 의해 새로운 제품 전략의 추진이 가능
  • Scrip Pipeline Watch : 주요 경쟁사 데이터의 연구개발 진척과 의약품 전략 개발
  • 동향 파악 - 시장 액세스와 치료 영역 : 주요 컨퍼런스의 보고, 주요 업계 리더와의 인터뷰
  • 금융 시장 : 상황과 활동, 주가 및 거래에 대한 영향에 관한 독자적 평가를 제시하는 Stockwatch란?
  • 매년 APAC 지역에서 성장하고 있는 기업을 상세 분석하는 SCRIP Asia 100
KSA 16.12.22

Scrip brings you market intelligence that goes beyond the headlines and focusses on delivering insight and analysis on the whole of the drug discovery, development and product life cycle value chain. Scrip gives you access to the latest licensing opportunities, partnership deals, company developments and constantly tracks product approvals across multiple therapy areas and product types.

With an unparalleled global network of contributors, Scrip is the trusted, comprehensive source of business critical market and competitor insights for the commercial pharmaceutical industry. It delivers deep insights and analysis about global commercial, business and finance developments and is the go-to- source for the industry.

What's new?

A subscription will give you increased content direct from editorial bureaus in China, India, Japan, Korea, Australia and the Pacific Rim with daily analysis of critical developments in these and other key markets in the AP region.

With access to English-language summaries of news about your company and competitors from the Chinese and Japanese press, you'll always be kept well informed on these and other key emerging markets.

Scrip now also publishes in-depth profiles of leading-edge start-up companies including new trends in business, technology, and financing. This will help you to identify new investment opportunities, create technology/product ideas and help you understand key trends in company start-ups and plan strategically for the future.

Leading industry insight on a leading industry platform

What's more, Scrip is published on a new user-friendly, interactive and responsive website. It allows you to access a large amount of relevant content from one place. The ability to create custom email alerts, numerous ways to refine and target search results, and simple tools to collect, send and share content allows you to tailor the service to your exact requirements.

Related articles, deals, companies, regions, therapy areas and other subjects are listed on the same page. This means that you can identify, find and read the content without having to look for it, making the website a valuable time saving resource.

Subscribe today and get access to:

  • Over 20 global analysts publishing real-time analysis accessible on mobile, tablet and PC.
  • Unique perspective from the US, Europe and developments in Asia Pacific.
  • In-depth profiles of leading-edge companies assessing new trends and technologies
  • Company Developments: Including M&A, deals, financial results, partnerships and more.
  • Product Developments: Including clinical trial results, approvals, launches, and postmarketing updates - so you can drive your own new product strategy.
  • Scrip Pipeline Watch: R&D progress for essential competitor data and drug strategy development.
  • Trend Spotting - Market Access and Therapeutic Areas: reporting from key conferences; interviews with key opinion leaders.
  • Unique access to Informa's suite of Pharma intelligence databases provide exclusive overviews and market forecasts so you can monitor target disease areas and compare strategies for pricing and reimbursement.
  • Financial Markets: Stockwatch column with our unique view of developments and activities and how they impact share prices and deals.
  • Scrip 100 - Dive deep into company analysis with Scrip 100, our annual ranking of the top 100 pharmaceutical companies in the world.
  • Scrip Asia 100 that dissects who's who in the growing APAC region annually.
  • Scan headlines to be up on the latest, and tailor the service to your specific needs with refined targeted searches, and custom email alerts and RSS feeds so you never miss a development.
  • “Ask the Analyst” exclusive client service to find out more about market access topics, developments, or trends to support presentations, proposals, or business critical decisions where your credibility is on the line.
Back to Top
전화 문의